Hans Morreau

6.2k total citations
77 papers, 3.9k citations indexed

About

Hans Morreau is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Hans Morreau has authored 77 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 30 papers in Molecular Biology and 23 papers in Pathology and Forensic Medicine. Recurrent topics in Hans Morreau's work include Genetic factors in colorectal cancer (21 papers), Pancreatic and Hepatic Oncology Research (15 papers) and Cancer Genomics and Diagnostics (12 papers). Hans Morreau is often cited by papers focused on Genetic factors in colorectal cancer (21 papers), Pancreatic and Hepatic Oncology Research (15 papers) and Cancer Genomics and Diagnostics (12 papers). Hans Morreau collaborates with scholars based in Netherlands, United Kingdom and United States. Hans Morreau's co-authors include Rob A.�E.�M. Tollenaar, Peter J.K. Kuppen, Cornelis J.�H. van de Velde, Geert Weeda, Jan de Wit, Harry van Steeg, Nynke Gillemans, Hein Putter, Alessandra d’Azzo and Jan H.J. Hoeijmakers and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Hans Morreau

74 papers receiving 3.9k citations

Peers

Countries citing papers authored by Hans Morreau

Since Specialization

Citations

This map shows the geographic impact of Hans Morreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Morreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Morreau more than expected).

Fields of papers citing papers by Hans Morreau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Morreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Morreau. The network helps show where Hans Morreau may publish in the future.

Co-authorship network of co-authors of Hans Morreau

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Morreau. A scholar is included among the top collaborators of Hans Morreau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Morreau. Hans Morreau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost‐effectiveness of pancreas surveillance: The CDKN2A‐p16‐Leiden cohort 2023 ·United European Gastroenterology Journal ·Isaura S. Ibrahim, Hans F. A. Vasen, Martin N.J.M. Wasser, Shirin Feshtali, Bert A. Bonsing, Hans Morreau, Akin Inderson, Wouter H. de Vos tot Nederveen Cappel, Wilbert B. van den Hout	10
2	A Paradoxical Role for Regulatory T Cells in the Tumor Microenvironment of Pancreatic Cancer 2022 ·Cancers ·Thomas P. Brouwer, Marieke E. Ijsselsteijn, Jan Oosting, Dina Ruano, Manon van der Ploeg, Frederike Dijk, Bert A. Bonsing, Arantza Fariña Sarasqueta, Hans Morreau, Alexander L. Vahrmeijer, Noel F.C.C. de Miranda	18
3	N-Glycomic Signature of Stage II Colorectal Cancer and Its Association With the Tumor Microenvironment 2020 ·Molecular & Cellular Proteomics ·(unknown), (unknown), Hans Dalebout, Stephanie Holst, Gabi W. van Pelt, Arantza Fariña Sarasqueta, Wilma E. Mesker, Rob A.�E.�M. Tollenaar, Hans Morreau, Manfred Wuhrer, Bram Heijs	48
4	Targeted next-generation sequencing of FNA-derived DNA in pancreatic cancer 2016 ·Journal of Clinical Pathology ·Babs G. Sibinga Mulder, J. Sven D. Mieog, Henricus J.M. Handgraaf, Arantza Fariña Sarasqueta, Hans F. A. Vasen, Thomas P. Potjer, Rutger‐Jan Swijnenburg, Saskia Luelmo, Shirin Feshtali, Akin Inderson, Alexander L. Vahrmeijer, Bert A. Bonsing, Tom van Wezel, Hans Morreau	23
5	Safety and efficacy of the addition of simvastatin to panitumumab in previously treated KRAS mutant metastatic colorectal cancer patients 2015 ·Anti-Cancer Drugs ·Jara M. Baas, (unknown), Monique M.E.M. Bos, Johanneke E.A. Portielje, Erdogan Batman, Tom van Wezel, Hans Morreau, Henk‐Jan Guchelaar, Hans Gelderblom	17
6	Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum 2015 ·The Journal of Clinical Endocrinology & Metabolism ·Nicolasine D. Niemeijer, Thomas Papathomas, Esther Korpershoek, Ronald R. de Krijger, Lindsey Oudijk, Hans Morreau, Jean‐Pierre Bayley, Frederik J. Hes, Jeroen C. Jansen, Winand N.M. Dinjens, Eleonora P.M. Corssmit	58
7	Double NF1 Inactivation Affects Adrenocortical Function in NF1Prx1 Mice and a Human Patient 2015 ·PLoS ONE ·(unknown), Daniela Hartl, Claus‐Eric Ott, Monika Osswald, Angela Huebner, Maja von der Hagen, (unknown), Jirko Kühnisch, Hans Morreau, Frederik J. Hes, Victor F. Mautner, Anja Harder, Sigrid Tinschert, Stefan Mundlos, Mateusz Kolanczyk	9
8	MicroRNA Classifier and Nomogram for Metastasis Prediction in Colon Cancer 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Inès J. Goossens-Beumer, Remco Derr, Henk P.J. Buermans, Jelle J. Goeman, Stefan Böhringer, Hans Morreau, Ulrich Nitsche, Klaus‐Peter Janssen, Cornelis J.�H. van de Velde, Peter J.K. Kuppen	26
9	Whole-Exome Sequencing Studies of Parathyroid Carcinomas Reveal NovelPRUNE2Mutations, Distinctive Mutational Spectra Related to APOBEC-Catalyzed DNA Mutagenesis and Mutational Enrichment in Kinases Associated With Cell Migration and Invasion 2014 ·The Journal of Clinical Endocrinology & Metabolism ·Willie Yu, John R. McPherson, Mark Stevenson, Ronald van Eijk, Hong Lee Heng, Paul Newey, Anna Gan, Dina Ruano, Dachuan Huang, Song Ling Poon, Choon Kiat Ong, Tom van Wezel, Branca Cavaco, Steve Rozen, Patrick Tan, Bin Tean Teh, Rajesh V. Thakker, Hans Morreau	72
10	Target-Enriched Next-Generation Sequencing Reveals Differences between Primary and Secondary Ovarian Tumors in Formalin-Fixed, Paraffin-Embedded Tissue 2014 ·Journal of Molecular Diagnostics ·(unknown), Dina Ruano, Ronald van Eijk, Gert Jan Fleuren, (unknown), (unknown), Carli M.J. Tops, Tom van Wezel, Hans Morreau	8
11	Activation of Tumor-Promoting Type 2 Macrophages by EGFR-Targeting Antibody Cetuximab 2011 ·Clinical Cancer Research ·Jan Pander, Moniek Heusinkveld, Tahar van der Straaten, Ekaterina S. Jordanova, Renée Baak-Pablo, Hans Gelderblom, Hans Morreau, Sjoerd H. van der Burg, Henk‐Jan Guchelaar, Thorbald van Hall	87
12	Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report 2011 ·Human Pathology ·Niki A. Ottenhof, Roeland F. de Wilde, Folkert H.M. Morsink, Wendy W.J. de Leng, Margreet G.E.M. Ausems, Hans Morreau, Richard van Hillegersberg, G. Johan A. Offerhaus, Anya N. Milne	5
13	Identification of a Quantitative MINT Locus Methylation Profile Predicting Local Regional Recurrence of Rectal Cancer 2010 ·Clinical Cancer Research ·Michiel F.G. de Maat, Cornelis J.�H. van de Velde, Anne Benard, Hein Putter, Hans Morreau, J. Han van Krieken, Elma Meershoek‐Klein Kranenbarg, (unknown), Rob A.�E.�M. Tollenaar, Dave S.�B. Hoon	21
14	Low penetrance of a SDHB mutation in a large Dutch paraganglioma family 2010 ·BMC Medical Genetics ·Frederik J. Hes, Marjan M. Weiss, (unknown), Noel F.C.C. de Miranda, (unknown), Bert A. Bonsing, Marcel P. M. Stokkel, Hans Morreau, Johannes A. Romijn, Jeroen C. Jansen, A. H. J. T. Vriends, Jean‐Pierre Bayley, Eleonora P.M. Corssmit	38
15	Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis 2004 ·Laboratory Investigation ·Anand G. Menon, (unknown), Hans Morreau, Hein Putter, Rob A.�E.�M. Tollenaar, Cornelis J.�H. van de Velde, Gert Jan Fleuren, Peter J.K. Kuppen	188
16	Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma 2003 ·The Journal of Pathology ·Carola J. Haven, Marjo van Puijenbroek, Marcel Karperien, (unknown), Hans Morreau	70
17	Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked toBRCA1, fails to support a role forBRCA1 in colorectal tumorigenesis 2000 ·International Journal of Cancer ·Tamara Peelen, (unknown), (unknown), Hans Morreau, Ronald van Eijk, M. van Vliet, Juul Wijnen, (unknown), H.B. Ginjaar, Ronald P. Zweemer, Fred H. Menko, Riccardo Fodde, (unknown), Hans F. A. Vasen, Cees J. Cornelisse, Peter Devilee	10
18	Degradation of Extracellular Matrix by Metastatic Follicular Thyroid Carcinoma Cell Lines: Role of the Plasmin Activation System 1999 ·Thyroid ·Johannes W. A. Smit, Gabri van der Pluijm, (unknown), Clemens W.G.M. Löwik, Hans Morreau, Bernard M. Goslings	26
19	A Mouse Model for the Basal Transcription/DNA Repair Syndrome Trichothiodystrophy 1998 ·Molecular Cell ·Jan de Boer, Jan de Wit, Harry van Steeg, Rob J. W. Berg, Hans Morreau, Pim Visser, Alan R. Lehmann, Marinus Durán, (unknown), Geert Weeda	161
20	Defective Transcription-Coupled Repair in Cockayne Syndrome B Mice Is Associated with Skin Cancer Predisposition 1997 ·Cell ·Gijsbertus T. J. van der Horst, Harry van Steeg, Rob J. W. Berg, Alain J. van Gool, Jan de Wit, Geert Weeda, Hans Morreau, Rudolf B. Beems, Coen F. van Kreijl, Frank R. de Gruijl, D. Bootsma, Jan H.J. Hoeijmakers	278

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact